ROIV

Latest SEC Filings & News for ROIV

2 most recent filings and news items mentioning ROIV. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/ROIV/news?limit=20"

Pull ROIV filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

EarningsAug 6, 2026Neutral

Roivant reports Q1 2026 financial results

Roivant reported Q1 2026 results, highlighting a $3.9B cash balance and a settlement with Moderna.

View filing at SEC.gov →

EarningsMay 20, 2026Positive

Roivant reports Q4 FY2026 results with $4.3B cash, multiple clinical updates

Roivant reported strong cash position of $4.3 billion and progress across pipeline including IMVT-1402 showing positive rheumatoid arthritis data, brepocitinib Breakthrough Therapy designation, and a $2.25 billion Moderna settlement. The company expects multiple clinical readouts

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.